Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Scientists capture the moving parts of the portal to the cell’s nucleus

The proteins of the nuclear pore complex flip-flop rapidly between two orientations as they let cargo through.

Study of 50,000 people finds brown fat may protect against many diseases

People with brown fat tissue tend to burn calories more quickly, but do they also enjoy better health? Now the largest study of its kind shows that brown fat is indeed linked to reduced risk of heart disease, type 2 diabetes, and several other conditions.

Llamas immune to coronavirus, what zebrafish are thinking, and other memorable science stories of 2020 

This year's scientific endeavors included multiple attacks on SARS-CoV-2—and a lot more. Here are the most memorable science stories to come out of Rockefeller labs, from cracking the code behind specific skin cancer subtypes to understanding what goes on inside a fish brain.

As COVID-19 vaccines emerge, the search for antiviral drugs continues

Scientists are digging through drug libraries of 430,000 compounds, in pursuit of an antiviral drug that can stop the novel coronavirus in its tracks.

A mediocre mutator 

Scientists developed a method to safely examine the ability of SARS-CoV-2 to escape future drugs or vaccines by mutating. Their initial results are reassuring.

Royalty Pharma and Pablo and Almudena Legorreta Support Development of Antibody-Based COVID-19 Therapy at The Rockefeller University

Royalty Pharma and The Rockefeller University announced generous gifts totaling $5,760,000 from Royalty Pharma and Pablo and Almudena Legorreta.

Scientists map the network of SARS-CoV-2’s helpers inside human cells

The virus must hijack a more than a hundred human proteins to replicate inside a cell. One of them stands out because it is an absolute requirement for infection by four different coronaviruses as well as by viruses that cause Zika, yellow fever, and other diseases.

Charles M. Rice formally receives 2020 Nobel Prize in a virtual ceremony

Rice was honored for research that contributed to a cure for hepatitis C. He accepted the Nobel medal and diploma at the Swedish Consulate in New York City.

Marina Caskey is promoted to professor of clinical investigation

Caskey, a clinician in the lab of Michel Nussenzweig, has spent the last decade working on clinical studies of experimental immune-based vaccines and therapies.

New five-year fundraising campaign has already received $200 million in gifts

The $675 million Campaign for the Convergence of Science and Medicine, launched July 1, 2019, aims to fulfill the priorities identified in the university’s 2020-2024 strategic plan.

Recent Awards and Honors

Josefina del Mármol and Shiri Gur-Cohen receive Tri-Institutional Breakout Awards

June 3, 2021

del Mármol, from Vanessa Ruta’s lab, and Gur-Cohen, from Elaine Fuchs’s lab, are recognized for their respective postdoctoral work.

Katya Vinogradova

Ekaterina V. Vinogradova named a Searle Scholar

May 20, 2021

Vinogradova receives the honor for her work designing chemical probes to dissect and alter immune protein function.

More awards and honors

Rockefeller in the News

The New York Times

“People who were infected and get vaccinated really have a terrific response, a terrific set of antibodies, because they continue to evolve their antibodies,” Dr. Nussenzweig said. “I expect that they will last for a long time.”

STAT News

“Depending potentially on the vaccination protocol, the vaccines are good enough to deal” with B.1.351 and other variants, said virologist Theodora Hatziioannou of Rockefeller University, an author of the study. “At least,” she added, “the variants we’ve seen up to now.” 

NPR

"People thought these genes were missing in birds and platypus, right? But they weren't missing. They just weren't sequenced with the older technologies," says Erich Jarvis.  

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.